Approved for NJ and NY UROVYSION – Urovysion™ is a sensitive and specific test used to diagnose urothelial carcinoma in urine. UroVysion has been approved by the FDA for both monitoring of patients with a history of bladder cancer and detection in patients with hematuria. Lincoln Reference Laboratory UroVysion Analysis offers: Turnaround time of 7-10 days Broad coverage by most private and public insurance. Specimen Requirements Specimen Collection – Urine Volume 33 mL urine mixed with 17 mL preservative (PreserveCyt) in Urine Collection/Cytology kit Container Use a large, open cup in […]

Approved for NJ and NY

UROVYSION – Urovysion™ is a sensitive and specific test used to diagnose urothelial carcinoma in urine. UroVysion has been approved by the FDA for both monitoring of patients with a history of bladder cancer and detection in patients with hematuria.

Lincoln Reference Laboratory UroVysion Analysis offers:

• Turnaround time of 7-10 days
• Broad coverage by most private and public insurance.

Specimen Requirements

Specimen Collection – Urine Volume 33 mL urine mixed with 17 mL preservative (PreserveCyt) in Urine Collection/Cytology kit Container

• Use a large, open cup in the kit to collect the urine specimen. Second void of the day is preferred.
• Slowly pour urine into two smaller PreserveCyt containers to the maximum fill.
• Tighten the lid until you hear a click in order to prevent leakage.